Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013
Burkholderia pseudomallei, an environmental gram-negative bacillus, is the causative agent of melioidosis and a bio-threat agent. Reports of B. pseudomallei isolation from soil and animals in East and West Africa suggest that melioidosis might be more widely distributed than previously thought. Beca...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2015-01-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/21/1/14-0762_article |
id |
doaj-14ac03bdaf484612a8ed9219451d28cc |
---|---|
record_format |
Article |
spelling |
doaj-14ac03bdaf484612a8ed9219451d28cc2020-11-24T21:52:57ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592015-01-01211404710.3201/eid2101.140762Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013W. Joost WiersingaEmma BirnieTassili A.F. WeehuizenAbraham S. AlabiMichaëla A.M. HusonRobert A. G. Huis in ’t VeldHarry K. MabalaGregoire K. AdzodaYannick Raczynski-HenkMeral EsenBertrand LellPeter G. KremsnerCaroline E. VisserVanaporn WuthiekanunSharon J. PeacockArie van der EndeDirek LimmathurotsakulMartin P. GrobuschBurkholderia pseudomallei, an environmental gram-negative bacillus, is the causative agent of melioidosis and a bio-threat agent. Reports of B. pseudomallei isolation from soil and animals in East and West Africa suggest that melioidosis might be more widely distributed than previously thought. Because it has been found in equatorial areas with tropical climates, we hypothesized that B. pseudomallei could exist in Gabon. During 2012–2013, we conducted a seroprevalance study in which we set up microbiology facilities at a large clinical referral center and prospectively screened all febrile patients by conducting blood cultures and testing for B. pseudomallei and related species; we also determined whether B. pseudomallei could be isolated from soil. We discovered a novel B. pseudomallei sequence type that caused lethal septic shock and identified B. pseudomallei and B. thailandensis in the environment. Our data suggest that melioidosis is emerging in Central Africa but is unrecognized because of the lack of diagnostic microbiology facilities.https://wwwnc.cdc.gov/eid/article/21/1/14-0762_articleBurkholderia pseudomalleiBurkholderia thailandensismelioidosisepidemiologyseroprevalanceAfrica |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
W. Joost Wiersinga Emma Birnie Tassili A.F. Weehuizen Abraham S. Alabi Michaëla A.M. Huson Robert A. G. Huis in ’t Veld Harry K. Mabala Gregoire K. Adzoda Yannick Raczynski-Henk Meral Esen Bertrand Lell Peter G. Kremsner Caroline E. Visser Vanaporn Wuthiekanun Sharon J. Peacock Arie van der Ende Direk Limmathurotsakul Martin P. Grobusch |
spellingShingle |
W. Joost Wiersinga Emma Birnie Tassili A.F. Weehuizen Abraham S. Alabi Michaëla A.M. Huson Robert A. G. Huis in ’t Veld Harry K. Mabala Gregoire K. Adzoda Yannick Raczynski-Henk Meral Esen Bertrand Lell Peter G. Kremsner Caroline E. Visser Vanaporn Wuthiekanun Sharon J. Peacock Arie van der Ende Direk Limmathurotsakul Martin P. Grobusch Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 Emerging Infectious Diseases Burkholderia pseudomallei Burkholderia thailandensis melioidosis epidemiology seroprevalance Africa |
author_facet |
W. Joost Wiersinga Emma Birnie Tassili A.F. Weehuizen Abraham S. Alabi Michaëla A.M. Huson Robert A. G. Huis in ’t Veld Harry K. Mabala Gregoire K. Adzoda Yannick Raczynski-Henk Meral Esen Bertrand Lell Peter G. Kremsner Caroline E. Visser Vanaporn Wuthiekanun Sharon J. Peacock Arie van der Ende Direk Limmathurotsakul Martin P. Grobusch |
author_sort |
W. Joost Wiersinga |
title |
Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 |
title_short |
Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 |
title_full |
Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 |
title_fullStr |
Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 |
title_full_unstemmed |
Clinical, Environmental, and Serologic Surveillance Studies of Melioidosis in Gabon, 2012–2013 |
title_sort |
clinical, environmental, and serologic surveillance studies of melioidosis in gabon, 2012–2013 |
publisher |
Centers for Disease Control and Prevention |
series |
Emerging Infectious Diseases |
issn |
1080-6040 1080-6059 |
publishDate |
2015-01-01 |
description |
Burkholderia pseudomallei, an environmental gram-negative bacillus, is the causative agent of melioidosis and a bio-threat agent. Reports of B. pseudomallei isolation from soil and animals in East and West Africa suggest that melioidosis might be more widely distributed than previously thought. Because it has been found in equatorial areas with tropical climates, we hypothesized that B. pseudomallei could exist in Gabon. During 2012–2013, we conducted a seroprevalance study in which we set up microbiology facilities at a large clinical referral center and prospectively screened all febrile patients by conducting blood cultures and testing for B. pseudomallei and related species; we also determined whether B. pseudomallei could be isolated from soil. We discovered a novel B. pseudomallei sequence type that caused lethal septic shock and identified B. pseudomallei and B. thailandensis in the environment. Our data suggest that melioidosis is emerging in Central Africa but is unrecognized because of the lack of diagnostic microbiology facilities. |
topic |
Burkholderia pseudomallei Burkholderia thailandensis melioidosis epidemiology seroprevalance Africa |
url |
https://wwwnc.cdc.gov/eid/article/21/1/14-0762_article |
work_keys_str_mv |
AT wjoostwiersinga clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT emmabirnie clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT tassiliafweehuizen clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT abrahamsalabi clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT michaelaamhuson clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT robertaghuisintveld clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT harrykmabala clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT gregoirekadzoda clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT yannickraczynskihenk clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT meralesen clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT bertrandlell clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT petergkremsner clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT carolineevisser clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT vanapornwuthiekanun clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT sharonjpeacock clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT arievanderende clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT direklimmathurotsakul clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 AT martinpgrobusch clinicalenvironmentalandserologicsurveillancestudiesofmelioidosisingabon20122013 |
_version_ |
1725873932543721472 |